Simvastatin
Flolipid, Simvastatin, Zocor, Cholib (simvastatin) is a small molecule pharmaceutical. Simvastatin was first approved as Flolipid on 1991-12-23. It is used to treat coronary artery disease, hypercholesterolemia, hyperlipoproteinemias, and hypertriglyceridemia in the USA. It has been approved in Europe to treat dyslipidemias. The pharmaceutical is active against 3-hydroxy-3-methylglutaryl-Coenzyme A reductase. Zocor's patent is valid until 2030-02-23 (FDA).
| Trade Name | Cholib |
|---|---|
| Common Name | Simvastatin |
| Indication | coronary artery disease, dyslipidemias, hypercholesterolemia, hyperlipoproteinemias, hypertriglyceridemia |
| Drug Class | Enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors) |
